Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000902664-26-001244·Beta Bionics, Inc.
Schedule 13G ownership disclosure
Beta Bionics Inc
Common Stock, par value $0.0001 per share · CUSIP: 08659B102
Event date: 2026-02-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Point72 Asset Management, L.P.
Shares: 2,290,023.00 · Class: 5.2%
- Point72 Capital Advisors, Inc.
Shares: 2,290,023.00 · Class: 5.2%
- Steven A. Cohen
Shares: 2,290,023.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-26-001244
- Form type
- SCHEDULE 13G
- Filer
- Beta Bionics, Inc.
- CIK
- CIK 1674632
- Filed
- Feb 23, 2026
- Reporting period
- Feb 18, 2026
- Description
- Schedule 13G beneficial ownership